chrisvoncsefalvay/vaers-outcomes huggingface dataset:
While working, had brain freezes and memory loss of what I had just typed. Got very confused.; While working, had brain freezes and memory loss of what I had just typed.; Got very confused.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 13Apr2021 at 08:30(at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. Concomitant medications included estrogen nos, progesterone (BIO IDENTICAL HORMONES) from an unknown date for an unknown indication. The patient previously took Codeine(MANUFACTURER UNKNOWN) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced brain freezes, memory loss of what she had typed while working and got very confused. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events brain freezes, memory loss and got very confused was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
very little red spot at the site of the injection , smaller than a bite of an insect ¨; received a lower dose than the recommended; A spontaneous report was received from a consumer concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events received a lower dose than the recommended, very little red spot at the site of the injection , smaller than a bite of an insect â¨, a friend knows people who works in another pharmacy next to the one she got the vaccine , was.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Mar 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 3 Mar 2021, the patient experienced the event(s) received a lower dose than the recommended . On 8 Mar 2021, the patient experienced the event(s) very little red spot at the site of the injection . smaller than a bite of an insect â¨. On an unknown date, the patient experienced the event(s) A friend knows people who works in another pharmacy next to the one she got the vaccine . was.  Treatment details included No.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), received a lower dose than the recommended, very little red spot at the site of the injection ,smaller than a bite of an insect â¨,a friend knows people who works in another pharmacy next to the one she got the vaccine ,was was unknown.
Vomiting 5 minutes post injection.   Vomiting 30 minutes post injection. Facial redness, spreading, 30 minutes post injection.
Information has been received from a registered nurse concerning a patient who was vaccinated with the first dose of Rotateq at 4 months of age. No symptoms were noted. It was unknown whether medical attention was sought. There was no product quality complaint. Additional information has been requested.
Immediately after receiving the vaccine, the patient had redness, shortness of breath and had significant elevations in her blood pressure and heart rate.
I remained at center for 30 minutes. After leaving, I developed hives within 10 minutes. The insides of my nostrils and to tongue swelled.; nostrils swelled; tongue swelled; This is a spontaneous report received from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 19Mar2021 at 16:00 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included asthma, penicillin and all variants allergy, latex allergy, plastic bags like grocery store allergy, pumpkins allergy.  Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 16:45 (as reported), the patient remained at centre for 30 minutes. After leaving, experienced hives within 10 minutes, the insides of nostrils and to tongue swelled. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome for the events hives, nostrils swelling and tongue swelling was resolved on an unknown date in 2021.   No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
This case was reported by a physician and described the occurrence of fibromyalgia in a 49-year-old female subject who was vaccinated with Flu vaccine (manufacturer unspecified). On 8 October 2010 the subject received a dose of Flu vaccine (unknown route, left arm). On 8 October 2010, immediately after vaccination with Flu vaccine, the subject experienced left arm burning. One to two days after vaccination with Flu vaccine, the subject developed generalized musculoskeletal pain and musculoskeletal weakness. The subject consulted a rheumatologist and was subsequently diagnosed with fibromyalgia. The physician considered the events were disabling. The subject was unable to work and was on disability at the time of reporting. At the time of reporting the events were unresolved. The physician was still investigating which brand of vaccine was administered. He stated that the events may have been related to the vaccine or may have been incidental.
1 week post receiving MMR, IPV and DTaP. Pt started vomiting and diarrhea. Also happened post 12 mo shots same time frame.
Uncontrollable chills/shaking for an hour, 102 fever, headache and muscle cramps
Major headache, loss of some vision in left eye headache last for three days vision has almost returned.
lt arm swollen to shoulder & neck starting 1/2hr p/vax lasted 2hrs
I had my shot at 845am on 5/4. By 5pm, I had developed a fever. By 8pm, I had body aches and the chills (I never experienced chills before). At 2am (5/5) I started throwing up for 2 hrs. All day 5/5, I had a fever and body aches. On 5/6, I still suffered minor body aches and fever. I took a Tylenol pill 500mg every 6 hrs starting 4pm on 5/4.
COUGH, WEAKNESS, INSOMNIA, ACUTE ON CHRONIC CKD, ACUTE ON CHRONIC CHF, EMESIS, DEATH Narrative:  1/12/21-PT REPORTED FEELING TIRED, UNABLE TO SLEEP AND EXPERIENCING DYSPNEA ON EXERTION THAT HE FEELS MAY BE RELATED TO RECENT COVID VACCINE 1/17/21-patient admitted to hospital due to 'severe abdominal pain;' received 1 unit PRBC due to symptomatic anemia and weakness (Hgb 8.4->7.1); dx: acute on chronic CHF exacerbation and difficulty breathing, acute kidney injury-CKD Stage IV; HPI includes chief complaint "weakness/sob since last night, cough x 2 weeks since covid vaccine;" HPI includes "pt states that for 2 weeks he has had SOB, cough, chills, body aches, and weakness, symptoms not improved over the last few days, more weak as of late" 1/28/21-transferred to facility 2/12/21-transferred back to hospital due to SOB, abnormal labs, pleural effusion 2/16/21-episode of coffee ground emesis 2/19/21-EGD showed ulcerative esophagitis and gastritis 2/24/21-transferred to SNF 3/9/21-admitted to hospital d/t multiple episodes of vomiting 3/10/21-pt passed away at hospital Possibility that acute inflammatory process triggered by vaccine resulted in patient's eventual death, but difficult to ascertain due to patient's various comorbidities. Patient never tested positive for COVID. Did not experience immediate ADR following 1st dose of vaccine. Did not received 2nd dose due to illness. Hospitalized multiple times following 1st vaccine dose.
This spontaneous report was received from a registered nurse and refers to an 8-week-old male patient. No information regarding the patient's pertinent medical history, drug reactions, allergies or concurrent conditions was reported. On 05-OCT-2017, the patient was vaccinated with improperly stored first doses of LIQUID PEDVAXHIB intramuscular injection (intramuscular route of administration, site of administration: left (specific localization not reported), dose not reported, lot # N003537, expiration date 17-NOV-2019), ROTARIX orally (dose was not reported; lot# Y5EJ3, expiration date was not reported), PEDIARIX (administered intramuscularly in right thigh; dose was not reported; lot#924Y3, expiration date was not reported) and PREVENAR 13 (administered intramuscularly, site of administration: left (specific localization not reported), lot#S35325, expiration date was not reported). The patient's concomitant medication included vitamin D (unspecified). There were no adverse effects reported. A drug treatment prescription was not required. The reporter stated that a temperature excursion above 46 degrees Fahrenheit (F) occurred on 04-OCT-2017, during shipment addition to the refrigerator and was lasting 36 minutes. The highest temperature was 47.6 degrees Fahrenheit (F). On that day, Digital Data Logger did not reflect the excursion, the temperatures had been cleared, prior to the evenings readings and temperatures were reflected in normal ranges. The temperature excursion was discovered on routine weekly download of Digital Data Logger on 09-OCT-2017. The reporter stated that was made contact with all involved vaccine manufacturers and all vaccines were determined to be viable. This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1711USA000885:
Symptoms started on Tuesday, sweats, chills ,body aches, headache and fever.  also, had 2 red spots on arm and both spots were swollen.   as of right now, wednesday oct 6 im still feeling body aches, headache and only one red spot on my arm swollen.
9MAR95 t104.9 APAP; 10MAR95 420AM t105.9 to ER; d/c'd 630AM; Motrin-tepid bath-CBC-BC; 11MAR95 t102.6 @ 730AM; 13MAR95 recovered-no sx;
Information has been received from a physician concerning a 12 year old female who on 23-NOV-2009 was vaccinated with a second 0.5 ml dose of GARDASIL (route, site and lot # not reported). Concomitant vaccine included a dose of MENACTRA and a dose of H1N1 on the same day (23-NOV-2009). The physician reported that the patient experienced fainting and seizure for 15 seconds after getting the second dose of GARDASIL on 23-NOV-2009. At the time of the report the outcome of the patient was recovered on an unspecified date. The patient sought unspecified medical attention. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
Mild ?COVID arm? one week after vaccination: rash, swelling and soreness around injection site.
102 fever for 5 hours so far, chills, body aches (legs, arms), diarrhea, occasional severe nausea, occasional headache, minor swelling in left armpit, low grade constant  pressure/pain on left and right side just above hips (kidneys, but front?).  All "known" side effects so far, but I got all of them essentially simultaneously. I didn't think I needed to report if it's under 72 hours since injection since it is all "known" but my mother pressured me to file a report :)  Spo2 levels 95-100, elevated heartrate (90-100), taste and smell are fine, no cough so far
Pt received DTaP and IPV in the same leg. She was seen 5/14/04 presenting an area of 14x12 cm erythema, induration, tenderness and warmth around injections site. Pt was treated with Cephalexin since local care did not help. seen today x follow-up. Significant improvement.
PER MOTHER, AS SOON AS THEY GOT HOME THEY TOOK THE BAND-AID OFF AND THEY SAW RASH WHERE THE  INJECTION SITE WAS.
In March I had VRE, sepsis, pneumonia, DKA, pancreatitis. UTI
Approximately 2 weeks post second Covid-19 vaccine, I came down with Shingles on my left side.
Several hours after receiving vaccine patient complained of vomiting, fever, diarrhea, and severe headache. These symptoms lasted into the next day and patient states she was lethargic with lingering fatigue and had loss of taste and smell. Patient self treated with water to rehydrate herself and she slept a lot- she did not take any meds.
8AUg94 1040AM pt recvd vax & w/in 3 mins pale/vomited only clear mucus & pink OPV; pt responsive/talking-alert (oriented); c/o throat hurt & stomach hurt (mid quadrant); had some nausea;
Wife reports that patient had a red streak going down his left arm.  He was taken to the ER and diagnosed with cellulitis.  Wife attributes this to the vaccine previously received.
Patient reported injection site rash  which appeared about 2 weeks later and last about 2 days.
p/vax pt exp a large, localized rxn to lt arm approx 5-6hr post vax;area was described as a red & inflamed area about 4 inches in diameter which was sore;T103 & was lethargic;pt sought unspecified med attention;CBC done to r/o cellulitis;
QUADRACEL vaccine was administered to a child under the age of 4 with no reported adverse event; Initial information received on 23-Mar-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 3 years old female patient and reporter reported Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine [Quadracel] was administered to a child under the age of 4 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis A Vaccine Inact (Havrix).  On 23-Feb-2023, the patient received 0.5 ml Total (1X) of suspect Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine Suspension for injection (Frequency - once) (Strength: Standard) (lot number: C5970AA; Expiry date: 02-FEB-2024) via intramuscular route in the left thigh for Immunisation.  On 23-Feb-2023, the reporter reported Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine was administered to a child under the age of 4 with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day).  It was reported, Caller states that she was waiting for a callback but she hasn't received it yet. Caller warm transferred. Physician reporting that QUADRACEL vaccine was administered to a child under the age of 4. She is inquiring if the dose can be counted as valid. This situation is reported as a medication error due to the vaccine administered to a child under the appropriate age.  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Initial report received from a health care professional in the USA on 09 May 2007. A 44 year old, female patient (with a medical history of allergy to penicillin and sinusitis) developed swelling and redness around the injection site, body aches, tingling and hand and finger pain on the left side and a red rash on the injection site arm (spots) - inferior to the injection site, one day after she received Adacel (lot number C2731AA) intramuscularly in the left deltoid on 01 May 2007. She did not have any laboratory or diagnostic tests done. She did not have any illness at the time of the vaccination. At the time of the report, she had not recovered. Same reporter as cases 2007-01632, 2007-01633 and 2007-01634.
Vomiting, fever, chills, insomnia, stomach ache, weakness in muscles, runny nose, lethargy.
Patient stated she started having injection site pain after receiving vaccine. She then stated she started having pain from her neck to down her right arm. She has tried to take ibuprofen and rotated between ice/heat packs. It has been 7 days and she is still experiencing a loss of movement in her right arm.
Headache, Sedation, Myalgia, Injection site discomfort, fatigue, and tiredness Narrative:
Day 10 I woke up with rash on both of my palms and soles of feet and sores inside mouth. Very itchy and burning. Over the next few days the rash completely covered my palms and soles of feet, and the inside of my mouth and tongue had more sores and was very sensitive. All of the affected areas were very swollen and painful. It is now almost 1 week later and the rashes are subsiding; palms are almost normal, mouth still hurts and feet feel much better but look very red still.
no additional adverse events; an expired dose of GARDASIL 9 was administered; This spontaneous report was received from a medical assistant referring to a specific patient of unknown age and gender.  No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.    On 09-AUG-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # R029900, 1 dosage form (route and site of administration not reported), for prophylaxis.  The vaccine had expired on 23-JUL-2021.  No adverse events were reported.  The reporter stated that the dose was properly stored up through time of administration. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R029900; expirationdate: 23-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
CLIENT HAD A VASOVAGAL RESPONSE IMMEDIATELY AFTER GIVING HIS VACCINE. CLIENT BECAME CLAMMY, FAINT, DIZZY, AND VERY PALE AFTER THE INJECTION. CLIENT RECOVERED AFTER 30 MINUTES, WITH WATER AND ELIVATION OF THE FEET AND REST.
Information has been received from a office nurse concerning a 15 year old female. The nurse reported that the patient who was not a patient of the office nurse, but was her daughters best friend, was vaccinated with the first dose of GARDASIL and right after receiving the vaccine the patient experienced seizures. The outcome of the event was unknown. Upon internal review, seizure was determined to be an other important medical event. No further information is available.
Mucousy, bloody stool developed within 24 hours of vaccine. No fever. No signs of abd pain.
Breakthrough case admission after 4 vaccines Pfizer 2/3/21 Lot# El9261l  Pfizer 2/24/21 Lot# EL9267;  Pfizer 10/19/21 Lot# FF8841 ; Moderna 4/28/22 Lot# 005M21A;
13 days after Covid booster I suffered sudden hearing loss and tinnitus (sounds like constant air) in my right ear. Dr  ordered 2 sets of steroids and 2 sets of acyclovir, but there has been no change.
Covid Pfizer vaccine was given, 0.3 ml, without diluant.  The writer attempted to speak with Mom on 8/26/2021 and left VM to return call.  Mom returned call on 8/27/2021 and writer updated Mom.  Writer told Mom that Medical Director and Health Officer were updated and consulted.  Mom stated that is fine' and is experiencin no signs of allergic reaction or adverse side effects.  Mom had no further questions or concerns.
Noted red blotchy areas 2 days post vaccination on bilateral inner thighs. Patient states he has yellow drainage if he expresses the areas. Has a photo of the rash. They are circular individual areas about 1 cm circumference. Each individual area is bright red with a open pinpoint area in the center. Some have a crusty area. He denies itching, burning. Denies rash in any additional areas post vaccination. Referred to see physician.
This day the patient mentioned received an additional dose of Pfizer Bivalent. Prior to giving this vaccine he was looked up in database and database only showed his first 2 primary doses given 01/18/2021 and 02/08/2021. He received the first Pfizer Bivalent dose 10/21/2022 but it was not shown in database or our own patients records due to his last name being misspelled therefore we were not aware on 02/09/2023 he had previously received his bivalent dose. No ill or negative effects were noted on this day.
Mother reports her son had headache at bed time on 1/23/08 and awoke with headache. Came home from school at lunch time feeling tired, had headache had full body rash that began to itch in afternoon mom treating with Tylenol and bedrest.
severe welting hives all over my body and face. The hives were extremely itchy and unbearable. They would resolve with Benadryl but then return once the Benadryl wore off. This lasted for multiple days until I was finally able to make it to see an allergist. as per allargist most likely a reaction to the covid booster I received 12 days prior to the start of the hives. as of 2/14/22 still being treated for the hives and I'm feeling much better but still developing them from time to time.
At about 30 hours developed fever as high as 100.8 April 3 late evening, chills, followed by muscle aches and joint aches, fatigue, mild diarrhea.  Fatigue and lower fever lasted through April 4.  No temperature as of morning April 5.
On May 7 2021 at night I experienced head ache and body aches; body felt very heavy, fatigues, and congestion.
Sudden appearance of thrombosed external hemorrhoid.  No associated constipation or other causes.
LARGE AREA OF THE UPPER ARM VISIBLY BRUISED WITHIN A DAY AFTER VACCINE ADMINISTRATION. PATIENT HAS DIFFICULTY LIFTING ARM DUE TO PAIN OVER THE NEXT 10+ DAYS. BRUISING IS IN REMISSION, BUT UNABLE TO ASSESS WHETHER PAIN HAS IMPROVED. RETURNED TO PHARMACY 10 DAYS LATER TO LET PHARMACY STAFF KNOW. UNABLE TO ASSESS PATIENT'S SELF-TREATMENT AT HOME.
headache, chills, fever, aching eyes, teeth and gums.  Motrin brought down symptoms within 12 hours, headache persisted for a week.
A few hours after receiving her Covid-19 Moderna vaccine on 3/25/2021, started with H/A. Took prescribed headache medication without relief. Unable to eat or sleep Thursday (after receiving vaccine), Friday, into Saturday. Seen in ER on Saturday evening (3/27/2021) at approximately 8 pm.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender On 08-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, 0.5 ml, (lot # K009105, expiration date 21-JAN-2016) (route and dose were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for each time were 24, 49 and R. The storage criteria was refrigerator (R). This is one of several reports received form the same source. Additional information has been requested.